Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.8650
+0.0350 (1.91%)
NASDAQ · Last Trade: Mar 19th, 2:48 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors